>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal
- PMID: 27803642
- PMCID: PMC5087582
- DOI: 10.7224/1537-2073.2015-097
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal
Abstract
Currently used classification schemes for multiple sclerosis (MS) have not taken into account disease severity, instead focusing on disease phenotype (ie, relapsing vs. progressive). In this article, we argue that disease severity adds a crucial dimension to the clinical picture and may help guide treatment decisions. We outline a practical, easy-to-implement, and comprehensive scheme for severity grading in MS put forward by our mentor, Professor Joseph Herbert. We believe that severity grading may help to better prognosticate individual disease course, formulate and test rational treatment algorithms, and enhance research efforts in MS.
Figures


Similar articles
-
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.Int J MS Care. 2016 Nov-Dec;18(6):314-323. doi: 10.7224/1537-2073.2016-051. Int J MS Care. 2016. PMID: 27999526 Free PMC article.
-
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.Iran J Neurol. 2013;12(1):1-8. Iran J Neurol. 2013. PMID: 24250889 Free PMC article.
-
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?Ther Adv Neurol Disord. 2024 Feb 7;17:17562864241229325. doi: 10.1177/17562864241229325. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38332854 Free PMC article. Review.
-
Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.Mult Scler Relat Disord. 2021 Sep;54:103109. doi: 10.1016/j.msard.2021.103109. Epub 2021 Jun 23. Mult Scler Relat Disord. 2021. PMID: 34237561
-
Diagnosis and treatment of progressive multiple sclerosis: A position paper.Eur J Neurol. 2023 Jan;30(1):9-21. doi: 10.1111/ene.15593. Epub 2022 Oct 25. Eur J Neurol. 2023. PMID: 36209464 Free PMC article. Review.
Cited by
-
Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden.Mult Scler J Exp Transl Clin. 2020 Oct 23;6(4):2055217320968597. doi: 10.1177/2055217320968597. eCollection 2020 Oct-Dec. Mult Scler J Exp Transl Clin. 2020. PMID: 33149932 Free PMC article.
-
Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era.Ther Adv Neurol Disord. 2018 Sep 11;11:1756286418793613. doi: 10.1177/1756286418793613. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30214486 Free PMC article.
-
Adherence to Mediterranean Diet Is Associated with Multiple Sclerosis Severity.Nutrients. 2023 Sep 16;15(18):4009. doi: 10.3390/nu15184009. Nutrients. 2023. PMID: 37764792 Free PMC article.
-
Ultra-processed foods consumption is associated with multiple sclerosis severity.Front Neurol. 2023 Jan 24;14:1086720. doi: 10.3389/fneur.2023.1086720. eCollection 2023. Front Neurol. 2023. PMID: 36761349 Free PMC article.
-
Clinical Characteristics of Early-Onset and Late-Onset Multiple Sclerosis in Patients from Lithuania.Medicina (Kaunas). 2025 Jan 13;61(1):107. doi: 10.3390/medicina61010107. Medicina (Kaunas). 2025. PMID: 39859088 Free PMC article.
References
-
- Sayao A, Devonshire V, Tremlett H. Longitudinal follow up of “benign” multiple sclerosis at 20 years. Neurology. 2007; 68: 496– 500. - PubMed
-
- Herbert J, Kappos L, O'Connor PW, et al. Effect of natalizumab on MS severity score in highly active patients. Poster presented at: 21st Annual Meeting of the Consortium of Multiple Sclerosis Centers; May 30–June 2, 2007; Washington, DC.
LinkOut - more resources
Full Text Sources
Other Literature Sources